insight
✂️ 성형 🏥 중증 🌐 전체
← 뒤로

ASO Author Reflections: Treating Secondary Triple Negative Breast Cancer in Younger Women.

Annals of surgical oncology 2026 Vol.33(5) p. 4605-4606 Breast Cancer Treatment Studies
TL;DR Innovative approaches, including the second-generation FGFR TKIs, monoclonal antibodies, FGF traps, antibody-drug conjugates, and synergistic combinations with immunotherapy or other receptor tyrosine kinase (RTK) inhibitors, are discussed to overcome resistance.
OpenAlex 토픽 · Breast Cancer Treatment Studies Male Breast Health Studies Multiple and Secondary Primary Cancers

Jacinto AI, Sauder C

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓
📝 환자 설명용 한 줄

Innovative approaches, including the second-generation FGFR TKIs, monoclonal antibodies, FGF traps, antibody-drug conjugates, and synergistic combinations with immunotherapy or other receptor tyrosine

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Ana Isabel Jacinto, Candice A. M. Sauder (2026). ASO Author Reflections: Treating Secondary Triple Negative Breast Cancer in Younger Women.. Annals of surgical oncology, 33(5), 4605-4606. https://doi.org/10.1245/s10434-025-19016-8
MLA Ana Isabel Jacinto, et al.. "ASO Author Reflections: Treating Secondary Triple Negative Breast Cancer in Younger Women.." Annals of surgical oncology, vol. 33, no. 5, 2026, pp. 4605-4606.
PMID 41501595
DOI 10.1245/s10434-025-19016-8

같은 제1저자의 인용 많은 논문 (2)